Kelvin M. Neu, M.D. was appointed a member of the Company’s Board in July 2016. Kelvin is a Managing Director of Baker Brothers Investments. The firm manages long-term investment funds focused on publicly traded life sciences companies, for major university endowments and foundations. Kelvin holds an A.B. Summa Cum Laude in Molecular Biology from Princeton University and an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology. He also trained for 3 years in the Immunology Ph.D. program at Stanford University.